US 10479784
Substituted pyrazin-2-amines as inhibitors of ATR kinase
granted A61PA61P35/00
Quick answer
US patent 10479784 (Substituted pyrazin-2-amines as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61P, A61P35/00